<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li><li><a href="#id18">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</span><br/>Reviewed date:[REDACTED] 08:29:44 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result1_attr1">CHOLESTEROL, TOTAL</td><td>163</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result1_attr2">HDL CHOLESTEROL</td><td>39</td><td>&gt; OR = 40 mg/dL</td><td/></tr><tr><td ID="result1_attr3">TRIGLYCERIDES</td><td>137</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result1_attr4">LDL-CHOLESTEROL</td><td>100</td><td/><td ID="result1_attr4_notes"><p>calculation, which is a validated novel method providing</p><p>with &gt; or = 2 CHD risk factors.</p><p>better accuracy than the Friedewald equation in the</p><p>LDL-C is now calculated using the [REDACTED]</p><p>[REDACTED] et al. JAMA. 2013;310(19): [REDACTED]-[REDACTED]</p><p>estimation of LDL-C.</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>Reference range: &lt;100</p></td></tr><tr><td ID="result1_attr5">CHOL/HDLC RATIO</td><td>4.2</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result1_attr6">NON HDL CHOLESTEROL</td><td>124</td><td>&lt;130 mg/dL (calc)</td><td ID="result1_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p></td></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:[REDACTED] 08:33:19 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result2_attr1">WHITE BLOOD CELL COUNT</td><td>6.7</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result2_attr2">RED BLOOD CELL COUNT</td><td>4.48</td><td>4.20-5.80 Million/uL</td><td/></tr><tr><td ID="result2_attr3">HEMOGLOBIN</td><td>12.4</td><td>13.2-17.1 g/dL</td><td/></tr><tr><td ID="result2_attr4">HEMATOCRIT</td><td>38.4</td><td>38.5-50.0 %</td><td/></tr><tr><td ID="result2_attr5">MCV</td><td>85.7</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result2_attr6">MCH</td><td>27.7</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result2_attr7">MCHC</td><td>32.3</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result2_attr8">RDW</td><td>14.8</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result2_attr9">PLATELET COUNT</td><td>212</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result2_attr10">MPV</td><td>10.6</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result2_attr11">ABSOLUTE NEUTROPHILS</td><td>2693</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result2_attr12">ABSOLUTE LYMPHOCYTES</td><td>3283</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result2_attr13">ABSOLUTE MONOCYTES</td><td>610</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result2_attr14">ABSOLUTE EOSINOPHILS</td><td>87</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result2_attr15">ABSOLUTE BASOPHILS</td><td>27</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result2_attr16">NEUTROPHILS</td><td>40.2</td><td/><td/></tr><tr><td ID="result2_attr17">LYMPHOCYTES</td><td>49.0</td><td/><td/></tr><tr><td ID="result2_attr18">MONOCYTES</td><td>9.1</td><td/><td/></tr><tr><td ID="result2_attr19">EOSINOPHILS</td><td>1.3</td><td/><td/></tr><tr><td ID="result2_attr20">BASOPHILS</td><td>0.4</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:[REDACTED] 08:33:19 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result3_attr1">GLUCOSE</td><td>86</td><td>65-99 mg/dL</td><td ID="result3_attr1_notes">           Fasting reference interval

</td></tr><tr><td ID="result3_attr2">UREA NITROGEN (BUN)</td><td>18</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result3_attr3">CREATININE</td><td>1.23</td><td>0.70-1.28 mg/dL</td><td/></tr><tr><td ID="result3_attr4">EGFR</td><td>63</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result3_attr5">BUN/CREATININE RATIO</td><td>SEE NOTE:</td><td>6-22 (calc)</td><td ID="result3_attr5_notes"><p/><p>   reference range.</p><p>   Not Reported: BUN and Creatinine are within</p></td></tr><tr><td ID="result3_attr6">SODIUM</td><td>139</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result3_attr7">POTASSIUM</td><td>5.2</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result3_attr8">CHLORIDE</td><td>104</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result3_attr9">CARBON DIOXIDE</td><td>24</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result3_attr10">CALCIUM</td><td>9.2</td><td>8.6-10.3 mg/dL</td><td/></tr><tr><td ID="result3_attr11">PROTEIN, TOTAL</td><td>7.7</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result3_attr12">ALBUMIN</td><td>4.2</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result3_attr13">GLOBULIN</td><td>3.5</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result3_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.2</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result3_attr15">BILIRUBIN, TOTAL</td><td>0.4</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result3_attr16">ALKALINE PHOSPHATASE</td><td>104</td><td>35-144 U/L</td><td/></tr><tr><td ID="result3_attr17">AST</td><td>14</td><td>10-35 U/L</td><td/></tr><tr><td ID="result3_attr18">ALT</td><td>11</td><td>9-46 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">TSH (899)</span><br/>Reviewed date:[REDACTED] 08:33:19 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result4_attr1">TSH</td><td>1.43</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:[REDACTED] 08:33:19 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result5_attr1">HEMOGLOBIN A1c</td><td>6.0</td><td>&lt;5.7 % of total Hgb</td><td ID="result5_attr1_notes"><p/><p>For someone without known diabetes, a hemoglobin</p><p>shifted HbA1c results compared to historical results.</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>of diabetes.</p><p>Currently, no consensus exists regarding use of</p><p>HbA1c performed on Roche platform.</p><p>diabetes, age, comorbid conditions, and other</p><p>A1c value between 5.7% and 6.4% is consistent with</p><p>This assay result is consistent with an increased risk</p><p>targets should be individualized based on duration of</p><p>considerations.</p><p>indicates that their diabetes is well controlled. A1c</p><p>Effective [REDACTED] a change in test platforms may have</p><p>For someone with known diabetes, a value &lt;7%</p><p>prediabetes and should be confirmed with a</p><p>follow-up test.</p></td></tr><tr><td colspan="4"><span class="content_span">PSA, TOTAL (5363)</span><br/>Reviewed date:[REDACTED] 08:33:19 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami
[REDACTED][REDACTED] Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result6_attr1">PSA, TOTAL</td><td>16.45</td><td>&lt; OR = 4.00 ng/mL</td><td ID="result6_attr1_notes"><p>different assay methods cannot be used</p><p>[REDACTED]). Comparison of serial PSA results should be</p><p>result will be approximately 20% lower when compared</p><p>interpreted with this fact in mind.</p><p>This test was performed using the Siemens</p><p>standardized against the WHO standard. The test</p><p>chemiluminescent method. Values obtained from</p><p>The total PSA value from this assay system is</p><p>interchangeably. PSA levels, regardless of</p><p>to the equimolar-standardized total PSA ([REDACTED]</p><p>value, should not be interpreted as absolute</p><p>evidence of the presence or absence of disease.</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>F/U | LAST APP-05/16/2023 </td></tr><tr><th>Diagnosis 1</th><td>Gross hematuria (R31.0)</td></tr><tr><th>Referral Organization</th><td>MCM Plantation [REDACTED] Rd.</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Family Medicine</td></tr><tr><th>Referred Provider</th><td>Ead, [REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Urology</td></tr><tr><th>Procedure 1</th><td>US URINE CAPACITY MEASURE (51798)</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Losartan Potassium 100 MG</td><td ID="instruction1">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Moderna Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization1notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization2">Moderna Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization2notes">  Immunization Given by from source eCW:: </td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div>No Information</div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Benign neoplasm of left adrenal gland (350831000119103)</td><td ID="Problem1">Benign neoplasm of left adrenal gland (D35.02)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems1notes">CT A/P 1 YEAR.</td></tr><tr><td>Problem</td><td>Homocystinuria (11282001)</td><td ID="Problem2">Homocystinuria (E72.11)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems2notes">OTC: FOLIC ACID 800 mcg DAILY.</td></tr><tr><td>Problem</td><td>267434003</td><td ID="Problem3">Mixed hyperlipidemia (E78.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems3notes">LOW CHOL AND FAT DIET.</td></tr><tr><td>Problem</td><td>Tobacco user (110483000)</td><td ID="Problem4">Nicotine dependence, cigarettes, uncomplicated (F17.210)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems4notes">SMOKING CESSATION. ENCOURAGE PT TO START USING NICODERM PATCH DAILY. S/P AORTIC SONO.</td></tr><tr><td>Problem</td><td>104931000119100</td><td ID="Problem5">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (I12.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems5notes">CONT RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &amp;lt; 130/80.</td></tr><tr><td>Problem</td><td>Simple chronic bronchitis (61937009)</td><td ID="Problem6">Simple chronic bronchitis (J41.0)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems6notes">TOBACCO CESSATION. IF SYMPTOMATIC WILL TX WITH ALBUTEROL PRN.</td></tr><tr><td>Problem</td><td>431856006</td><td ID="Problem7">Chronic kidney disease, stage 2 (mild) (N18.2)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems7notes">Pathophysiology of the diagnosis discussed, including measures to minimize progression of the disease like avoiding NSAIDS and other nephrotoxic meds. Blood pressure control to below 130/80.</td></tr><tr><td>Problem</td><td>Enlarged prostate (249607009)</td><td ID="Problem8">Enlarged prostate without lower urinary tract symptoms (N40.0)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems8notes">OFF TAMSULOSIN. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td></tr><tr><td>Problem</td><td>473021009</td><td ID="Problem9">Erectile dysfunction due to diseases classified elsewhere (N52.1)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems9notes">RX: TADALFIL 20 MG Q 36 HR PRN. VIAGRA WAS NOT EFFECTIVE. DO NOT TAMSULOSIN WITHIN 4 HR OF TAKING PDE INHIB. SMOKING CESSATION</td></tr><tr><td>Problem</td><td>9414007</td><td ID="Problem10">Impaired glucose tolerance (oral) (R73.02)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems10notes">AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td></tr><tr><td>Problem</td><td>591000119102</td><td ID="Problem11">Immunization not carried out because of patient refusal (Z28.21)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems11notes">PT REFUSES INFLUNEZA AND PNEUMONIA VACCINES.</td></tr><tr><td>Problem</td><td>Aneurysm of iliac artery (13290008)</td><td ID="Problem12">Aneurysm of iliac artery (I72.3)</td><td>[REDACTED]</td><td>Active</td><td>confirmed</td><td/><td ID="problems12notes">CT A/P WITH CONTRAST ANNUALLY . TIGHT BP CONTROL</td></tr><tr><td>Problem</td><td>13645005</td><td ID="Problem13">Chronic obstructive pulmonary disease, unspecified COPD type (J44.9)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems13notes">+CT CHEST FINDINGS: 2-2023. SMOKING CESSATION, OPTIONS DISCUSSED.</td></tr><tr><td>Problem</td><td>461441000124103</td><td ID="Problem14">Aortic arch atherosclerosis (I70.0)</td><td/><td>Active</td><td>confirmed</td><td/><td ID="problems14notes">+ CXR FINDINGS (11-2022). SMOKING CESSATION. TIGHT BP AND CHOLESTEROL MANAGEMENT.</td></tr><tr><td>Problem</td><td>Overweight (238131007)</td><td ID="Problem15">Overweight (E66.3)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td ID="problems15notes">WT LOSS.   DAILY WALKING.</td></tr><tr><td>Problem</td><td>Urinary tract infectious disease (68566005)</td><td ID="Problem16">Urinary tract infection, site not specified (N39.0)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Screening for malignant neoplasm of colon (275978004)</td><td ID="Problem17">Encounter for screening for malignant neoplasm of colon (Z12.11)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Screening for malignant neoplasm of prostate (444822002)</td><td ID="Problem18">Encounter for screening for malignant neoplasm of prostate (Z12.5)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Endocrine/metabolic screening (268549006)</td><td ID="Problem19">Encounter for screening for other suspected endocrine disorder (Z13.29)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>59621000</td><td ID="Problem20">Essential (primary) hypertension (I10)</td><td/><td>Inactive</td><td>confirmed</td><td/><td ID="problems20notes">INCREASE RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &amp;lt; 130/80.</td></tr><tr><td>Problem</td><td>Elevated PSA (396152005)</td><td ID="Problem21">Elevated prostate specific antigen [PSA] (R97.20)</td><td>[REDACTED]</td><td>Inactive</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>412768003</td><td ID="Problem22">BMI 24.0-24.9, adult (Z68.24)</td><td/><td>Inactive</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>75 /min</td><td>[REDACTED]</td><td ID="vital1notes">2 LB WT LOSS</td></tr><tr><th ID="vital2">Temperature</th><td>97.3 degrees Fahrenheit</td><td>[REDACTED]</td><td ID="vital2notes">2 LB WT LOSS</td></tr><tr><th ID="vital3">Respiratory Rate</th><td>18 /min</td><td>[REDACTED]</td><td ID="vital3notes">2 LB WT LOSS</td></tr><tr><th ID="vital4">Height-cm</th><td>170.18 cm</td><td>[REDACTED]</td><td ID="vital4notes">2 LB WT LOSS</td></tr><tr><th ID="vital5">Oximetry</th><td>95 %</td><td>[REDACTED]</td><td ID="vital5notes">2 LB WT LOSS</td></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>80 mm Hg</td><td>[REDACTED]</td><td ID="vital6notes">2 LB WT LOSS</td></tr><tr><th ID="vital7">Weight-kg</th><td>70.76 kg</td><td>[REDACTED]</td><td ID="vital7notes">2 LB WT LOSS</td></tr><tr><th ID="vital8">Height</th><td>67 in</td><td>[REDACTED]</td><td ID="vital8notes">2 LB WT LOSS</td></tr><tr><th ID="vital9">Blood pressure systolic</th><td>134 mm Hg</td><td>[REDACTED]</td><td ID="vital9notes">2 LB WT LOSS</td></tr><tr><th ID="vital10">Weight</th><td>156 lbs</td><td>[REDACTED]</td><td ID="vital10notes">2 LB WT LOSS</td></tr><tr><th ID="vital11">BMI</th><td>24.43 kg/m2</td><td>[REDACTED]</td><td ID="vital11notes">2 LB WT LOSS</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure2">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure3">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure4">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure5">HEDIS: COA Medication Review</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure6">HEDIS: COA Functional Status</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure7">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure8">HEDIS: Mammogram (If Resulted)</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure9">HEDIS: Fall Risk (If completed)</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure10">HEDIS: COA Pain Not Present</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure11">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure12">HEDIS: Depression Screening - Negative</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure13">HEDIS: Fall Risk - No Falls or 1 fall</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure14">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure15">HEDIS: Blood Pressure Diastolic 80-89</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Plantation [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM Plantation [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Impaired glucose tolerance (oral) R73.02 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Aortic arch atherosclerosis I70.0 ; Aneurysm of iliac artery I72.3 ; Homocystinuria E72.11 ; Mixed hyperlipidemia E78.2 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Simple chronic bronchitis J41.0 ; Nicotine dependence, cigarettes, uncomplicated F17.210 ; Benign neoplasm of left adrenal gland D35.02 ; Enlarged prostate without lower urinary tract symptoms N40.0 ; Erectile dysfunction due to diseases classified elsewhere N52.1 ; Immunization not carried out because of patient refusal Z28.21 and BMI 24.0-24.9, adult Z68.24</td></tr><tr><td>MCM Plantation [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Impaired glucose tolerance (oral) R73.02 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Enlarged prostate without lower urinary tract symptoms N40.0 ; Aortic arch atherosclerosis I70.0 ; Aneurysm of iliac artery I72.3 ; Mixed hyperlipidemia E78.2 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Simple chronic bronchitis J41.0 ; Nicotine dependence, cigarettes, uncomplicated F17.210 ; Benign neoplasm of left adrenal gland D35.02 ; Erectile dysfunction due to diseases classified elsewhere N52.1 ; Homocystinuria E72.11 ; Immunization not carried out because of patient refusal Z28.21 and BMI 24.0-24.9, adult Z68.24</td></tr><tr><td>MCM Plantation [REDACTED]</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Impaired glucose tolerance (oral) R73.02 ; Enlarged prostate without lower urinary tract symptoms N40.0 ; Mixed hyperlipidemia E78.2 and Erectile dysfunction due to diseases classified elsewhere N52.1</td></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms N40.0 ; Erectile dysfunction due to diseases classified elsewhere N52.1 ; Mixed hyperlipidemia E78.2 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Impaired glucose tolerance (oral) R73.02 and Essential (primary) hypertension I10</td></tr><tr><td>MCM Plantation Pine Island Rd.</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms N40.0 ; Impaired glucose tolerance (oral) R73.02 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Mixed hyperlipidemia E78.2 and Essential (primary) hypertension I10</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Impaired glucose tolerance (oral) (ICD-10 - R73.02)</td><td>AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Impaired glucose tolerance (oral) (ICD-10 - R73.02)</td><td>AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms (ICD-10 - N40.0)</td><td>OFF TAMSULOSIN. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms (ICD-10 - N40.0)</td><td>OFF TAMSULOSIN. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Impaired glucose tolerance (oral) (ICD-10 - R73.02)</td><td>AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Impaired glucose tolerance (oral) (ICD-10 - R73.02)</td><td>AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Erectile dysfunction due to diseases classified elsewhere (ICD-10 - N52.1)</td><td>RX: TADALFIL 20 MG Q 36 HR PRN. VIAGRA WAS NOT EFFECTIVE. DO NOT TAMSULOSIN WITHIN 4 HR OF TAKING PDE INHIB. SMOKING CESSATION</td><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>+CT CHEST FINDINGS: 2-2023. SMOKING CESSATION, OPTIONS DISCUSSED.</td><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td>+CT CHEST FINDINGS: 2-2023. SMOKING CESSATION, OPTIONS DISCUSSED.</td><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Aortic arch atherosclerosis (ICD-10 - I70.0)</td><td>+ CXR FINDINGS (11-2022). SMOKING CESSATION. TIGHT BP AND CHOLESTEROL MANAGEMENT.</td><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms (ICD-10 - N40.0)</td><td>OFF TAMSULOSIN. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms (ICD-10 - N40.0)</td><td>OFF TAMSULOSIN. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td/><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>CONT RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Aortic arch atherosclerosis (ICD-10 - I70.0)</td><td>+ CXR FINDINGS (11-2022). SMOKING CESSATION. TIGHT BP AND CHOLESTEROL MANAGEMENT.</td><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Aneurysm of iliac artery (ICD-10 - I72.3)</td><td>CT A/P WITH CONTRAST ANNUALLY . TIGHT BP CONTROL</td><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Homocystinuria (ICD-10 - E72.11)</td><td>START OTC: FOLIC ACID 800 mcg DAILY.</td><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Erectile dysfunction due to diseases classified elsewhere (ICD-10 - N52.1)</td><td>RX: TADALFIL 20 MG Q 36 HR PRN. VIAGRA WAS NOT EFFECTIVE. DO NOT TAMSULOSIN WITHIN 4 HR OF TAKING PDE INHIB. SMOKING CESSATION</td><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Impaired glucose tolerance (oral) (ICD-10 - R73.02)</td><td>AVOID SWEETS AND WHITE FLOUR PRODUCTS.</td><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Aneurysm of iliac artery (ICD-10 - I72.3)</td><td>CT A/P WITH CONTRAST ANNUALLY . TIGHT BP CONTROL</td><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td>INCREASE RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td>INCREASE RX: LOSARTAN 100 MG DAILY. STOP SMOKING. DASH DIET. GOAL BP &lt; 130/80.</td><td/><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td>LOW CHOL AND FAT DIET.</td><td/><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td>Pathophysiology of the diagnosis discussed, including measures to minimize progression of the disease like avoiding NSAIDS and other nephrotoxic meds. Blood pressure control to below 130/80.</td><td/><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td>Pathophysiology of the diagnosis discussed, including measures to minimize progression of the disease like avoiding NSAIDS and other nephrotoxic meds. Blood pressure control to below 130/80.</td><td/><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Simple chronic bronchitis (ICD-10 - J41.0)</td><td>TOBACCO CESSATION. IF SYMPTOMATIC WILL TX WITH ALBUTEROL PRN.</td><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Simple chronic bronchitis (ICD-10 - J41.0)</td><td>TOBACCO CESSATION. IF SYMPTOMATIC WILL TX WITH ALBUTEROL PRN.</td><td/><td/></tr><tr><td ID="ref35">[REDACTED]</td><td>Nicotine dependence, cigarettes, uncomplicated (ICD-10 - F17.210)</td><td>SMOKING CESSATION. ENCOURAGE PT TO START USING NICODERM PATCH DAILY. S/P AORTIC SONO.</td><td/><td/></tr><tr><td ID="ref36">[REDACTED]</td><td>Nicotine dependence, cigarettes, uncomplicated (ICD-10 - F17.210)</td><td>SMOKING CESSATION. ENCOURAGE PT TO START USING NICODERM PATCH DAILY. S/P AORTIC SONO.</td><td/><td/></tr><tr><td ID="ref37">[REDACTED]</td><td>Benign neoplasm of left adrenal gland (ICD-10 - D35.02)</td><td>CT A/P 1 YEAR.</td><td/><td/></tr><tr><td ID="ref38">[REDACTED]</td><td>Benign neoplasm of left adrenal gland (ICD-10 - D35.02)</td><td>CT A/P 1 YEAR.</td><td/><td/></tr><tr><td ID="ref39">[REDACTED]</td><td>Erectile dysfunction due to diseases classified elsewhere (ICD-10 - N52.1)</td><td>RX: TADALFIL 20 MG Q 36 HR PRN. VIAGRA WAS NOT EFFECTIVE. DO NOT TAMSULOSIN WITHIN 4 HR OF TAKING PDE INHIB. SMOKING CESSATION</td><td/><td/></tr><tr><td ID="ref40">[REDACTED]</td><td>Enlarged prostate without lower urinary tract symptoms (ICD-10 - N40.0)</td><td>ENCOURAGE TAMSULOSIN 0.4 MG QHS. INCREASE WATER INTAKE. S/P PROSTATE BX x 3 (NEGATIVE).</td><td/><td/></tr><tr><td ID="ref41">[REDACTED]</td><td>Erectile dysfunction due to diseases classified elsewhere (ICD-10 - N52.1)</td><td>RX: TADALFIL 20 MG Q 36 HR PRN. VIAGRA WAS NOT EFFECTIVE. DO NOT TAMSULOSIN WITHIN 4 HR OF TAKING PDE INHIB. SMOKING CESSATION</td><td/><td/></tr><tr><td ID="ref42">[REDACTED]</td><td>Homocystinuria (ICD-10 - E72.11)</td><td>OTC: FOLIC ACID 800 mcg DAILY.</td><td/><td/></tr><tr><td ID="ref43">[REDACTED]</td><td>Immunization not carried out because of patient refusal (ICD-10 - Z28.21)</td><td>PT REFUSES INFLUNEZA AND PNEUMONIA VACCINES.</td><td/><td/></tr><tr><td ID="ref44">[REDACTED]</td><td>Immunization not carried out because of patient refusal (ICD-10 - Z28.21)</td><td>PT REFUSES INFLUNEZA AND PNEUMONIA VACCINES.</td><td/><td/></tr><tr><td ID="ref45">[REDACTED]</td><td>BMI 24.0-24.9, adult (ICD-10 - Z68.24)</td><td/><td/><td/></tr><tr><td ID="ref46">[REDACTED]</td><td>BMI 24.0-24.9, adult (ICD-10 - Z68.24)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">CBC (INCLUDES DIFF/PLT) (6399)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">CBC (INCLUDES DIFF/PLT) (6399)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">HEMOGLOBIN A1c (496)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">PSA, TOTAL (5363)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">TSH (899)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">HEDIS: Blood Pressure Diastolic 80-89</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">HEDIS: Blood Pressure Diastolic Less than 80</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">HEDIS: Blood Pressure Systolic 130-139</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">HEDIS: COA Functional Status</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest13">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest14">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest15">HEDIS: COA Pain Not Present</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest16">HEDIS: Fall Risk (If completed)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest17">HEDIS: Mammogram (If Resulted)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest18">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest19">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest20">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest21">HEDIS: Depression Screening - Negative</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest22">HEDIS: Fall Risk - No Falls or 1 fall</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest23">FECAL GLOBIN BY IMMUNOCHEMISTRY (11290)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest24">CHEST PA &amp; LATERAL</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest25">- CT ABDOMEN/PELVIS W/WO CONT</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest26">VENIPUNCT, ROUTINE*</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest27">HEDIS: Blood Pressure Diastolic 80-89</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest28">HEDIS: COA Functional Status</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest29">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest30">HEDIS: COA Medication Review</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest31">HEDIS: COA Pain Not Present</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest32">HEDIS: Depression Screening (If completed)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest33">HEDIS: Fall Risk (If completed)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest34">HEDIS: Tobacco Non-User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest35">HEDIS: Tobacco User</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest36">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest37">HEDIS: BMI 22 - 30</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest38">HEDIS: Depression Screening - Negative</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest39">HEDIS: Fall Risk - No Falls or 1 fall</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest40">LIPID PANEL WITH RATIOS (19543)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest41">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest42">HEMOGLOBIN A1c (496)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest43">PSA, TOTAL (5363)</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 08:45:00 AM, [REDACTED]-1849, [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Humana Medicare PPO</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>H68704016</td><td/><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>benign prostatic hypertrophy:  S/P MRI</td><td/></tr><tr><td>Diverticulosis</td><td/></tr><tr><td>HOMOCYSTENEMIA</td><td/></tr><tr><td>ADRENAL ADENOMA: BILATERAL</td><td/></tr><tr><td>ANEURYSM: R COMMON ILIAC ARTERY. (3.2 CM)</td><td/></tr><tr><td>aortic atherosclerosis</td><td/></tr><tr><td>fatty liver</td><td/></tr><tr><td>AAA:  3.45 CM</td><td/></tr><tr><td>impaired glucose tolerance</td><td/></tr><tr><td>hyperlipidemia</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>PROSTATE BX -BENIGN (PROSTATITIS)</td><td>5/2023</td></tr><tr><td>PROSTATE BX: REASON FOR SURGERY WAS BENIGN</td><td>2/2021</td></tr><tr><td>FISSURECTOMY</td><td/></tr><tr><td>PROSTATE BX: REASON FOR SURGERY WAS X 3 (BENIGN)</td><td/></tr></tbody></table></div><h3><a name="id18" href="#toc">Progress Notes</a></h3><div>No Information</div><br/><br/>
</body></html>